Fraud charges filed against diagnostic company
This article was originally published in Clinica
The US Securities and Exchange Commission has brought fraud charges against the now defunct company, Novatek International, reports Barron's, a US business weekly. The company is alleged to have issued false press releases two years ago, claiming it had revenues of $400 million in non-existent transactions, concerning sales of HIV blood test kits in South America.
You may also be interested in...
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.